Molecular assays for quantitative and qualitative detection of influenza virus and oseltamivir resistance mutations

Journal of Molecular Diagnostics

Volumn 15, Issue 3, 2013, Pages 347-354

  Van Der Vries, Erhard ^a   Anber, Jeer ^a   Van Der Linden, Anne ^a   Wu, Yingbin ^a   Maaskant, Jolanda ^a   Stadhouders, Ralph ^a   Van Beek, Ruud ^a   Rimmelzwaan, Guus ^a   Osterhaus, Albert ^a   Boucher, Charles ^a   Schutten, Martin ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR; SIALIDASE;

ANTIVIRAL RESISTANCE; ARTICLE; CONTROLLED STUDY; EVALUATION; HUMAN; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PANDEMIC INFLUENZA; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RESISTANCE MUTATION; SENSITIVITY ANALYSIS; VALIDITY; VIRUS DETECTION; VIRUS MUTATION;

DRUG RESISTANCE, VIRAL; EVALUATION STUDIES AS TOPIC; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; MUTATION; NEURAMINIDASE; OSELTAMIVIR; REAL-TIME POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY;

HUMAN INFLUENZA VIRUS; INFLUENZA B VIRUS; ORTHOMYXOVIRIDAE;

EID: 84876496569     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2012.11.007     Document Type: Article

References (28)

1. R.J. Garten, C.T. Davis, C.A. Russell, B. Shu, S. Lindstrom, and A. Balish Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans Science 325 2009 197 201
2. J.H. Kreijtz, A.D. Osterhaus, and G.F. Rimmelzwaan Vaccination strategies and vaccine formulations for epidemic and pandemic influenza control Hum Vaccin 5 2009 126 135
3. D. Kumar, M.G. Michaels, M.I. Morris, M. Green, R.K. Avery, C. Liu, L. Danziger-Isakov, V. Stosor, M. Estabrook, S. Gantt, K.A. Marr, S. Martin, F.P. Silveira, R.R. Razonable, U.D. Allen, M.E. Levi, G.M. Lyon, L.E. Bell, S. Huprikar, G. Patel, K.S. Gregg, K. Pursell, D. Helmersen, K.G. Julian, K. Shiley, B. Bono, V.R. Dharnidharka, G. Alavi, J.S. Kalpoe, S. Shoham, G.E. Reid, A. Humar American Society of Transplantation H1N1 Collaborative Study Group Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study Lancet Infect Dis 10 2010 521 526
4. F.Y. Aoki, M.D. Macleod, P. Paggiaro, O. Carewicz, A. El Sawy, C. Wat, M. Griffiths, E. Waalberg, P. Ward IMPACT Study Group Early administration of oral oseltamivir increases the benefits of influenza treatment J Antimicrob Chemother 51 2003 123 129
5. A.S. Monto The role of antivirals in the control of influenza Vaccine 21 2003 1796 1800
6. S.H. Hauge, S. Dudman, K. Borgen, A. Lackenby, and O. Hungnes Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08 Emerg Infect Dis 15 2009 155 162
7. J. Gooskens, M. Jonges, E.C. Claas, A. Meijer, and A.C. Kroes Prolonged influenza virus infection during lymphocytopenia and frequent detection of drug-resistant viruses J Infect Dis 199 2009 1435 1441
8. M.G. Ison, L.V. Gubareva, R.L. Atmar, J. Treanor, and F.G. Hayden Recovery of drug-resistant influenza virus from immunocompromised patients: a case series J Infect Dis 193 2006 760 764
9. M. Baz, Y. Abed, J. McDonald, and G. Boivin Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child Clin Infect Dis 43 2006 1555 1561
10. L. Cohen-Daniel, Z. Zakay-Rones, I.B. Resnick, M.Y. Shapira, M. Dorozhko, N. Mador, E. Greenbaum, and D.G. Wolf Emergence of oseltamivir-resistant influenza A/H3N2 virus with altered hemagglutination pattern in a hematopoietic stem cell transplant recipient J Clin Virol 44 2009 138 140
11. O. Ferraris, and B. Lina Mutations of neuraminidase implicated in neuraminidase inhibitors resistance J Clin Virol 41 2008 13 19
12. L.V. Gubareva, M.N. Matrosovich, M.K. Brenner, R.C. Bethell, and R.G. Webster Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus J Infect Dis 178 1998 1257 1262
13. A.C. Hurt, J.L. McKimm-Breschkin, M. McDonald, I.G. Barr, N. Komadina, and A.W. Hampson Identification of a human influenza type B strain with reduced sensitivity to neuraminidase inhibitor drugs Virus Res 103 2004 205 211
14. A.C. Hurt, J.K. Holien, M. Parker, A. Kelso, and I.G. Barr Zanamivir-resistant influenza viruses with a novel neuraminidase mutation J Virol 83 2009 10366 10373
15. van der Vries E, Stelma FF, Boucher CA: Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus [Erratum appeared in N Engl J Med 2011, 364:1182 and in N Engl J Med 2011, 364:290]. N Engl J Med 363:1381-1382
16. C.L. Ward, M.H. Dempsey, C.J. Ring, R.E. Kempson, L. Zhang, D. Gor, B.W. Snowden, and M. Tisdale Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement J Clin Virol 29 2004 179 188
17. E. van der Vries, M. Jonges, S. Herfst, J. Maaskant, A. Van der Linden, J. Guldemeester, G.I. Aron, T.M. Bestebroer, M. Koopmans, A. Meijer, R.A. Fouchier, A.D. Osterhaus, C.A. Boucher, and M. Schutten Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase J Clin Virol 47 2010 34 37
18. A. Clancy, B. Crowley, H. Niesters, and C. Herra The development of a qualitative real-time RT-PCR assay for the detection of hepatitis C virus Eur J Clin Microbiol Infect Dis 27 2008 1177 1182
19. G.F. Rimmelzwaan, M. Baars, E.C. Claas, and A.D. Osterhaus Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro J Virol Methods 74 1998 57 66
20. van der Vries E, Jonges M, Herfst S, Maaskant J, Van der Linden A, Guldemeester J, Aron GI, Bestebroer TM, Koopmans M, Meijer A, Fouchier RA, Osterhaus AD, Boucher CA, Schutten M: Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase. J Clin Virol 47:34-37
21. R. Stadhouders, S.D. Pas, J. Anber, J. Voermans, T.H. Mes, and M. Schutten The effect of primer-template mismatches on the detection and quantification of nucleic acids using the 5′ nuclease assay J Mol Diagn 12 2010 109 117
22. E. van der Vries, and M. Schutten Satisfying the need for rapid diagnosis of new variant influenza A H1N1 Expert Rev Mol Diagn 10 2010 251 253
23. J. Saldanha, A. Heath, N. Lelie, G. Pisani, and M.Y. Yu A World Health Organization International Standard for hepatitis A virus RNA nucleic acid amplification technology assays Vox Sang 89 2005 52 58
24. V.M. Deyde, T. Nguyen, R.A. Bright, A. Balish, B. Shu, S. Lindstrom, A.I. Klimov, and L.V. Gubareva Detection of molecular markers of antiviral resistance in influenza A (H5N1) viruses using a pyrosequencing method Antimicrob Agents Chemother 53 2009 1039 1047
25. S. Bolotin, A.V. Robertson, A. Eshaghi, C. De Lima, E. Lombos, E. Chong-King, L. Burton, T. Mazzulli, and S.J. Drews Development of a novel real-time reverse-transcriptase PCR method for the detection of H275Y positive influenza A H1N1 isolates J Virol Methods 158 2009 190 194
26. M.J. Carr, N. Sayre, M. Duffy, J. Connell, and W.W. Hall Rapid molecular detection of the H275Y oseltamivir resistance gene mutation in circulating influenza A (H1N1) viruses J Virol Methods 153 2008 257 262
27. S. Duwe, and B. Schweiger A new and rapid genotypic assay for the detection of neuraminidase inhibitor resistant influenza A viruses of subtype H1N1, H3N2, and H5N1 J Virol Methods 153 2008 134 141
28. M.B. Townsend, J.A. Smagala, E.D. Dawson, V. Deyde, L. Gubareva, A.I. Klimov, R.D. Kuchta, and K.L. Rowlen Detection of adamantane-resistant influenza on a microarray J Clin Virol 42 2008 117 123